Atlas Trials

Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.

Clinical trial NCT03620461 · COMPLETED

Trial details

NCT number
NCT03620461
Sponsor
Galician Research Group on Digestive Tumors
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Pancreatic Cancer
Start date
2013-12-01
Primary completion
2013-12-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.